Antitumor studies. Part 1: Design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents

Bioorganic & Medicinal Chemistry
2007.0

Abstract

Novel 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides were prepared as a new class of antitumor agents and showed significant antitumor activities against NCI-H 460, HCT 116, A 431, CCRF-HSB-2, andKB cell lines. In vivo investigation, 2-deoxo-10-methyl-2-phenyl-5-deazaflavin exhibited the effective antitumor activity against A 431 human adenocarcinoma cells transplanted subcutaneously into nude mouse. Furthermore, AutoDock study has been done by binding of the flavin analogs into PTK pp60(c-src), where a good correlation between their IC(50) and AutoDock binding free energy was exhibited. In particular, 2-deoxo-2-phenylflavin-5-oxides exhibited the highest potential binding affinity within the binding pocket of PTK.

Knowledge Graph

Similar Paper

Antitumor studies. Part 1: Design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents
Bioorganic & Medicinal Chemistry 2007.0
Antitumor studies. Part 3: Design, synthesis, antitumor activity, and molecular docking study of novel 2-methylthio-, 2-amino-, and 2-(N-substituted amino)-10-alkyl-2-deoxo-5-deazaflavins
Bioorganic & Medicinal Chemistry 2007.0
Antitumor studies. Part 5: Synthesis, antitumor activity, and molecular docking study of 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins
Bioorganic & Medicinal Chemistry 2008.0
Antitumor studies. Part 4: Design, synthesis, antitumor activity, and molecular docking study of novel 2-substituted 2-deoxoflavin-5-oxides, 2-deoxoalloxazine-5-oxides, and their 5-deaza analogs
Bioorganic & Medicinal Chemistry 2008.0
Antitumor studies – Part 2: Structure–activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase
European Journal of Medicinal Chemistry 2008.0
Synthesis, biological active molecular design, and molecular docking study of novel deazaflavin–cholestane hybrid compounds
Bioorganic & Medicinal Chemistry 2008.0
Synthesis and cytotoxicity of 5-deazaflavins containing o- and p-quinone moieties
Bioorganic & Medicinal Chemistry Letters 1997.0
Synthesis and evaluation of nitro 5-deazaflavins as novel bioreductive antitumor agents
Bioorganic & Medicinal Chemistry Letters 1995.0
Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity
Journal of Medicinal Chemistry 2012.0
Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues
Bioorganic & Medicinal Chemistry 2007.0